This medication works by suppressing appetite and slowing the rate at which food leaves the stomach, which supports reduced calorie intake
While GLP-1 medications are generally considered safe and effective, some evidence suggests that they may increase the risk of gallstones in some individuals
Peptides are not small molecules
When considering drug interactions, healthcare providers categorize them by their clinical significance: major, moderate, minor, or unknown
| Last Updated: January 30th, 2024 Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA) that is manufactured by Eli Lilly and Company
Posologie Recommande : 500mg en 120 units/bote rpond aux attentes des consommateurs pour l'clat de la peau et la dtoxification